Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Neuro drugs dumped by AbbVie are now heading to Neurocrine for $100M up front
MedCity News
Tue, 11/23/21 - 09:40 am
AbbVie
Neurocrine
neurological disorders
ICER: Unsubstantiated drug price increases cost US $1.67B in 2020, but overall net increases lower than years past
Endpoints
Tue, 11/16/21 - 10:35 am
ICER
drug pricing
Humira
AbbVie
AbbVie, University of Chicago extend oncology research collaboration
Pharmaceutical Business Review
Sat, 11/13/21 - 09:52 pm
AbbVie
University of Chicago
R&D
oncology
ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again
Fierce Biotech
Thu, 11/4/21 - 10:27 am
BeiGene
Brukinsa
leukemia
clinical trials
AbbVie
JNJ
Imbruvica
California judge sides with drugmakers in $50B opioid lawsuit
Endpoints
Tue, 11/2/21 - 11:02 am
opioids
opioid crisis
California
JNJ
AbbVie
Endo Pharmaceuticals
Teva Pharmaceutical
legal
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
atopic dermatitis
eczema
nocturnal scratch
digital endpoint
AbbVie
Janssen
JNJ
Novartis
Pfizer
UCB Pharma
digital pharma
AbbVie claims first FDA okay for presbyopia drug therapy
Pharmaforum
Mon, 11/1/21 - 10:59 am
AbbVie
FDA
presbyopia
AGN-190584
Even AbbVie CEO can't confirm Rinvoq's sales as FDA mulls JAK label
Fierce Pharma
Mon, 11/1/21 - 10:55 am
AbbVie
Pharma CEOs
Rick Gonzalez
Rinvoq
FDA
Merck's Keytruda close to becoming top-selling drug in the world
Beckers Hospital Review
Mon, 11/1/21 - 10:39 am
Merck
Keytruda
AbbVie
Humira
drug sales
AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial
Pharmaforum
Sat, 10/30/21 - 10:48 pm
AbbVie
ABV-951
Parkinson's Disease
clinical trials
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
NASDAQ
Sat, 10/30/21 - 10:43 pm
AbbVie
clinical trials
cariprazine
major depressive disorder
AbbVie (ABBV) Tops Q3 Earnings Estimates
Zacks.com
Fri, 10/29/21 - 10:55 am
AbbVie
earnings
Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment
BioSpace
Thu, 10/28/21 - 10:16 pm
AbbVie
Parkinson's Disease
ABBV-951
clinical trials
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Biohaven
migraines
Nurtec ODT
Amgen
AbbVie
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Boehringer Ingelheim
Humira
biosimilars
interchangeable biosimilars
Cyltezo
AbbVie
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Boehringer Ingelheim
AbbVie
Humira
interchangeable biosimilars
biosimilars
Cyltezo
FDA
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders
Fierce Pharma
Mon, 10/18/21 - 10:49 pm
Regeneron
Novo Nordisk
Eli Lilly
AbbVie
television ads
DTC ads
diabetes
immunology
Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'
Fierce Pharma
Mon, 10/18/21 - 11:10 am
Revance Therapeutics
FDA
daxibotulinumtoxinA
Botox
Daxi
AbbVie
AbbVie's Botox patent lawsuit is 'very unlikely to derail' Revance's rival launch: analysts
Fierce Pharma
Mon, 10/11/21 - 09:46 pm
AbbVie
Botox
patents
ReVance
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Fierce Pharma
Fri, 10/8/21 - 10:32 am
Alvotech
AbbVie
patents
Humira
trade secrets
biosimilars
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »